STAT3-INHIBITOREN

Patent europeic · EP4070790 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4070790
Numer da la dumonda
EP22161820
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
18-04-2019
Publitgà
12-10-2022
Concedì
03-06-2026
La protecziun finescha il pli tard
17-04-2039
Proxima taxa annuala scadenta
30-04-2027
Classas IPC
A61K 31/18 (2006.01)
C07C 311/21 (2006.01)
A61P 11/00 (2006.01)
A61P 25/00 (2006.01)
A61P 31/12 (2006.01)
A61P 35/02 (2006.01)
A61P 37/08 (2006.01)
A61P 43/00 (2006.01)
C07C 311/29 (2006.01)
Prioritad
US 201862659872 P 19.04.2018
US 201962793491 P 17.01.2019
Derivà da
EP19788688
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 29-07-2026

    Owner

    Owner
    Tvardi Therapeutics, Inc., 3 Sugar Creek Center Boulevard, Suite 525, Sugar Land, TX 77478, USA, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030-3411, USA → Tvardi Operating Company, Inc., 3 Sugar Creek Center Boulevard, Suite 525, Sugar Land, TX 77478, USA, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030-3411, USA

    Published in Swissreg on 29.07.2026

  2. 03-06-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 03.06.2026

Partidas

Inventur

WIED, Sofia De Achaval

77459 Missouri City, US

BAUTA, William E.

78230 San Antonio, US

CANTRELL, William R. Jr.

78253 San Antonio, US

TWEARDY, David John

77005 Houston, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.